Home › Endometrial Cancer › Michigan › Kalamazoo
Endometrial Cancer clinical trials in Kalamazoo, MI
3 studies for Endometrial Cancer are looking for participants at sites in and around Kalamazoo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Bronson Methodist Hospital, Kalamazoo
- West Michigan Cancer Center, Kalamazoo
- Bronson Battle Creek, Battle Creek · 21 mi away
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Bronson Methodist Hospital, Kalamazoo
- West Michigan Cancer Center, Kalamazoo
- Bronson Battle Creek, Battle Creek · 21 mi away
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Bronson Methodist Hospital, Kalamazoo
- West Michigan Cancer Center, Kalamazoo
- Bronson Battle Creek, Battle Creek · 21 mi away
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
- Oklahoma City, OK25 studies
Other studies in Kalamazoo
- Melanoma7 studies
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Burkitt Lymphoma5 studies
- Acute Myeloid Leukemia5 studies
- Ovarian Cancer5 studies
- Colorectal Cancer5 studies
- Pancreatic Cancer4 studies
- Breast Cancer4 studies
- Rectal Cancer4 studies
- Colon Cancer4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.